Search Results 1741-1750 of 17050 for monoclonal antibody

  1. CAR-T Cell Therapy Program - Clinical trials

    ... antibody (ANCA) associated vasculitis using primary samples and/or patient derived xenograft models. CD19-Directed CAR-T Cell Therapy for the Treatment of ...

  2. Coagulation factor viia (intravenous route) - Side effects & uses - Mayo Clinic

    Factor VIIa is used to treat and prevent bleeding episodes in patients with Hemophilia A or B who have formed antibodies against other clotting proteins (eg ...

  3. Neuromyelitis Optica Clinical Consortium (NMOCC) Clinical Database Development for Neuromyelitis Optica Spectrum Disorders - Mayo Clinic

    NMO seropositive patients are those who have a circulating antibody, NMO-IgG, against aquaporin-4. NMO seronegative patients are those who likely have NMO ...

  4. A Study of the SynCardia Temporary Total Artificial Heart Used as End Point Therapy - Mayo Clinic

    ... antibodies [PRAs]) as determined by the implanting center at time of implant screening assessment; On optimal medical management and failing to respond or ...

  5. A First-in-Human Study Of MEN2312 In Adults With Advanced Breast Cancer - Mayo Clinic

    * Up to 6 prior lines of systemic therapy (including up to 2 prior lines consisting of chemotherapy, cytotoxic antibody drug conjugate, or a combination of ...

  6. A Study to Better Understand if Diet and Metabolism are Connected with MS Relapses and Disease Progress in Patients with Pediatric-onset MS - Mayo Clinic

    Are positive for AQP4 antibodies or high suspicion of neuromyelitis optica spectrum disorder; OR; Are pregnant or breast-feeding. Participating Mayo Clinic ...

  7. A Study to Evaluate HH2853 in Patients with Relapsed/Refractory Non-Hodgkin's Lymphomas or Advanced Solid Tumors - Mayo Clinic

    Any cancer-directed therapy (chemotherapy, antibody therapy, radiotherapy, hormonal ... 200 IU/mL; HCV antibody test results are positive, and HCV (hepatitis C ...

  8. Clinical trials - Oncology (Medical)

    ... antibodies and the factors that may determine disease progression and treatment response. Pagination Clinical studies. PrevPrevious Page · Go to page 1919 · Go ...

  9. A Study of the Safety and Effectiveness of Atezolizumab Combined with Etoposide, and Carboplatin for Patients with Untreated Extensive-Stage Small Cell Lung Cancer - Mayo Clinic

    Prior treatment with cluster of differentiation 137 (CD137) agonists or immune checkpoint blockade therapies, anti-PD1, and anti-PD-L1 therapeutic antibody ...

  10. Diphtheria, tetanus, acellular pertussis, polio vaccine (intramuscular route) - Mayo Clinic

    The vaccine works by causing the body to produce its own protection (antibodies) against these diseases. This vaccine is given only to children 4 to 6 years ...